Advancement of global health: key messages from the Disease Control Priorities Project

  title={Advancement of global health: key messages from the Disease Control Priorities Project},
  author={Ramanan Laxminarayan and Anne Mills and Joel G. Breman and Anthony R. Measham and George Alleyne and Mariam Claeson and Prabhat Jha and Philip Musgrove and Jeffrey T. Y. Chow and Sonbol A. Shahid-Salles and Dean T Jamison},
  journal={The Lancet},

Figures and Tables from this paper

Measuring Neglect
  • P. Hotez
  • Medicine
    PLoS neglected tropical diseases
  • 2007
In this issue of PLoS Neglected Tropical Diseases, a series of articles devoted to NTD disease burden and the controversies about how the chronic and disabling features of these conditions should be best evaluated are begun.
International consultation on long-term global health research priorities, research capacity and research uptake in developing countries
The outcomes from this consultation survey provide valuable insights into how DfID stakeholders prioritise research, including the growing importance of non-communicable disease as a global health research priority, being placed above infectious diseases.
Planning to improve global health: the next decade of tuberculosis control.
The Global Plan to Stop TB 2006-2015 is a road map for policy-makers and managers of national programmes. It sets out the key actions needed to achieve the targets of the Millennium Development Goals
Interventions for the prevention of cardiovascular diseases: a protocol for a systematic review of economic evaluations in low-income and middle-income countries
This systematic review protocol has been prepared according to the Preferred Reporting Items for Systematic reviews and Meta-analyses for Protocols (PRISMA-P) 2015 statement and aims to synthesise the current literature on economic evaluations of interventions for primary and secondary cardiovascular disease prevention in LMICs.
Health Gains and Financial Risk Protection Afforded by Treatment and Prevention of Diarrhea and Pneumonia in Ethiopia: An Extended Cost-Effectiveness Analysis
Extended cost-effectiveness analysis (ECEA) provides a tool with which to gain a more complete understanding of the health and financial benefits associated with different health policies and interventions, specifically in health gains, FRP and equity benefits.


Disease Control Priorities in Developing Countries
This first edition provides information on disease control interventions for the most common diseases and injuries in developing countries to help them define essential health service packages and offers preventive and case management guidelines critical to improving the quality of care.
Millions Saved: Proven Successes In Global Health
A compilation of 17 large scale successful health intervention stories to make the case that some programs have worked / producing major health and welfare benefits that significantly outweigh the costs, and six "wows" that challenge critics of international development assistance.
Intervention Cost-Effectiveness: Overview of Main Messages
This chapter provides broad conclusions on the economic efficiency of using these interventions to improve health, and the resulting avertable burden of disease, for 319 interventions covering nearly every disease condition considered in the volume.
Measuring the Global Burden of Disease and Risk Factors, 1990–2001
This chapter begins with a brief history of the work on burden of disease, including a discussion of the nature and origins of the disability-adjusted life year (DALY) as a measure of disease burden, and summarizes the methods and findings of the 2001 GBD study.
Priorities in Health
This companion guide to Disease Control Priorities in Developing Countries, second edition, speeds the diffusion of life-saving knowledge by distilling the contents of the larger volume into an
The intolerable burden of malaria: what's new, what's needed. Proceedings of the Third Pan-African MIM Conference. November, 18-20, 2002. Arusha, Tanzania.
This supplement aims to strengthen the capacity of scientists and control workers and their institutions to address the burden of malaria through research and development of sciencebased policies and actions in the malarious countries.
Global burden of disease and risk factors
Global Burden of Disease and Risk Factors examines the comparative importance of diseases, injuries, and risk factors; it incorporates a range of new data sources to develop consistent estimates of incidence, prevalence, severity and duration, and mortality for 136 major diseases and injuries.
Health in an Age of Globalization
Disease has traveled with goods and people since the earliest times. Armed globalization spread disease, to the extent of eliminating entire populations. The geography of disease shaped patterns of
Conquering the intolerable burden of malaria: what's new, what's needed: a summary.
Progress in malaria vaccine research has been substantial over the past five years; 35 candidate malaria vaccines are in development, many of which are in clinical trials, and key to evaluation of vaccine effectiveness will be collection and prompt analysis of epidemiologic information.